A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） Patient
Clinical trial NCT03557099 · COMPLETED
Trial details
- NCT number
- NCT03557099
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2019-10-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.